Posted in | News | Laser | Medical Optics

Aesthera's Isolaz Laser Device Featured on Good Morning America

Aesthera's Isolaz platform was hailed by New York Dermatologist, Dr. Doris Day, as a unique in-office treatment for Rosacea on the January 21st show of ABC News' Good Morning America.

The Isolaz developed by Aesthera Corporation is a proprietary combination of pneumatic energy and broad band light. Best recognized as the gold standard for acne treatment, the Isolaz is the only laser or light based device cleared for the treatment of inflammatory acne, comedonal acne and pustular acne. Doris Day, MD, FAAD, a board certified dermatologist who practices in New York City has treated several hundred patients for Acne now uses a different treatment tip on the Isolaz for the in-office treatment for Rosacea. "The Isolaz is an extremely effective treatment offering for my Rosacea patients. The procedure takes under 10 minutes, and is associated with no pain or downtime," she says. "The Isolaz is invaluable, especially for patients who are resistant to antibiotics or choose not to take them," she adds.

According to the National Rosacea Society, 14 million Americans suffer from Rosacea. Rosacea manifests itself as acute redness on the face, cheeks and forehead. Its acne like effects often cause significant psychological harm, impacting patients' self esteem and self confidence. "While there are no cures for Rosacea, Isolaz provides a safe and effective treatment option to control this life disruptive skin disorder," Dr. Day concludes.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.